Randomized Open-label and Non-inferiority Clinical Trial
Conditions: Hepatitis C Interventions: Drug: Specialist - Epclusa 400Mg-100Mg Tablet; Drug: Non- specialist - Epclusa 400Mg-100Mg Tablet Sponsors: Oswaldo Cruz Foundation; Conselho Nacional de Desenvolvimento Cient ífico e Tecnológico Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
Immunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and Adolescents
Conditions: HAV; Hepatitis A; Hep A; Vaccine-Preventable Diseases Interventions: Biological: Mevac-A vaccine; Biological: Havrix 720 Junior Sponsors: Chiang Mai University; Faculty of Medicine, Chiang Mai University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B Patients
Conditions: Chronic Hepatitis b Interventions: Drug: Terbinafine; Drug: Placebo; Drug: Tenofovir Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
Impact of Hepatitis B Virus Genotype on Treatment Response in Children With Chronic Hepatitis B
Conditions: Chronic Hepatitis b Interventions: Drug: antiviral treatment Sponsors: Ly Hoa Anh Minh Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Safety, Tolerability Phase Ia Study of XT1061 in Single and Multiple Doses in Healthy Subjects
Conditions: Chronic Hepatitis b Interventions: Drug: Test drug XT1061 capsules and placebo,Single dose group; Drug: Test drug XT1061 capsules and placebo ，Multiple dosing group; Drug: Test drug XT1061 capsules and placebo，Food Impact Group Sponsors: Xi ' an Xintong Pharmaceutical Research Co.,Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Efficacy and Durability of Hepatitis A Vaccination in Patients With Advanced Fibrosis and Cirrhosis
Conditions: Cirrhosis; Hep A; Vaccination Interventions: Biological: HAVRIX Sponsors: Mahidol University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
The Effect of Heart Sound and White Noise on Pain and Physiological Parameters During Hepatitis B Vaccine Injection
Conditions: Pain, Acute; Newborn; Vitality Interventions: Behavioral: Heart Sound; Behavioral: White Noise Sponsors: Bart ın Unıversity Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
A Multicenter Prospective Clinical Cohort Study on the Pathogen Spectrum of Severe Hepatitis (Liver Failure) Complicated With Infection
Conditions: Liver Failure Sponsors: Zhejiang University; Beijing Ditan Hospital; Beijing YouAn Hospital; Huashan Hospital; Qilu Hospital of Shandong University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
IMARA for Black Male Caregivers and Girls Empowerment (IMAGE)
Conditions: Sexually Transmitted Infections (Not HIV or Hepatitis); HIV Infections; Sexual Behavior Interventions: Behavioral: IMARA for Black Male Caregivers and Girls Empowerment; Behavioral: Time-matched control program Sponsors: University of Illinois at Chicago; University of Michigan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
HDV-Europe: Prevalence and Outcome of HDV in HIV/HBV Coinfection
Conditions: Hepatitis D Interventions: Other: HDV screening Sponsors: University Hospital, Bonn; Swiss HIV Cohort Study; ICONA Cohort; Amsterdam UMC; Royal Free Hospital NHS Foundation Trust; King ' s College London; University Hospital of Cologne; Goethe University; Heinrich-Heine University, Duesseldorf; University Hospital, Essen; ICH Hamburg; Praxiszentrum Hohenstaufenring K öln; Sorbonne University; Henri Mondor University Hospital; Hospital Universitario Infanta Leonor; Hospital General Universitario Gregorio Marañon; GEPCOI (Portuguese Group of Coinfection) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
Conditions: Chronic Hepatitis B Interventions: Drug: GST-HG131; Drug: Placebo to match GST-HG131 Sponsors: Fujian Akeylink Biotechnology Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials
HCV Tappt Adherence Study
Conditions: Hepatitis C Interventions: Other: Use of Tappt App Sponsors: University of Illinois at Chicago; Synchronyx; American Society of Health-System Pharmacists Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials
GSK Receives US FDA Fast Track Designation for Bepirovirsen in Chronic Hepatitis B
London, UK 12 February 2024 -- GSK plc (LSE/NYSE: GSK) announced today that the US Food and Drug Administration (FDA) has granted Fast Track designation for bepirovirsen, an investigational antisense oligonucleotide (ASO) for the treatment of... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 12, 2024 Category: Pharmaceuticals Source Type: clinical trials
Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis Patients
Conditions: Autoimmune Hepatitis Interventions: Dietary Supplement: Dietary assignment Sponsors: Indiana University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
Find HDV and Determine Its Status in Turkey
Conditions: Chronic Hepatitis D Infection With Hepatitis B Carrier State (Diagnosis); Fibrosis, Liver; Hepatocellular Carcinoma; Cirrhosis, Liver; Transmission Vertical Interventions: Diagnostic Test: Anti Delta Sponsors: Yasar Bay ındır; SOUTHEAST NEUROLOGY AND INFECTIOUS DISEASES SOCIETY; Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
